Literature DB >> 20491895

Brugada-like cardiac disease in myotonic dystrophy type 2: report of two unrelated patients.

S Rudnik-Schöneborn1, M Schaupp, A Lindner, W Kress, E Schulze-Bahr, S Zumhagen, M Elbracht, K Zerres.   

Abstract

BACKGROUND: Myotonic dystrophy type 2 (DM2) is an autosomal dominant multisystem disorder caused by CCTG repeat expansions within intron 1 of the ZNF9 gene on chromosome 3q. Cardiac conduction disturbances, supraventricular arrhythmias, and cardiomyopathy are described in DM2 but Brugada-like features have not yet been reported. Brugada syndrome (BS) is a genetically heterogeneous cardiac conduction disorder which is characterized by a significant ST-segment elevation upon ECG evaluations and bears an increased risk for sudden cardiac death. CASE REPORTS: We report two unrelated patients with genetically confirmed DM2 who developed clinical relevant cardiac arrhythmias with syncopal events from 35 (patient 1) and 47 years (patient 2). Brugada-like ECG findings were present in both patients. Family history was negative for BS, but the mothers of both index patients were also affected by DM2 and had different ventricular rhythm disturbances. SCN5A gene sequencing revealed an unknown genetic variant c.4140 C > A, p.N1380K, in patient 1, while no mutation was detected in patient 2. DISCUSSION: Our observations may suggest that Brugada-like cardiac arrhythmias can occur in DM2, as this seems also to be the case in DM1. The chance association of two independent inherited disorders has to be considered and cannot be excluded in one of our patients. However, on statistical grounds, this possibility cannot explain all observed cases of DM with Brugada-like cardiac disease.

Entities:  

Mesh:

Year:  2011        PMID: 20491895     DOI: 10.1111/j.1468-1331.2010.03077.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  5 in total

Review 1.  Brugada phenocopy: new terminology and proposed classification.

Authors:  Adrian Baranchuk; Timothy Nguyen; Min Hyung Ryu; Francisco Femenía; Wojciech Zareba; Arthur A M Wilde; Wataru Shimizu; Pedro Brugada; Andrés R Pérez-Riera
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-08-13       Impact factor: 1.468

Review 2.  Heart Disease in Disorders of Muscle, Neuromuscular Transmission, and the Nerves.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Korean Circ J       Date:  2016-03-21       Impact factor: 3.243

3.  iPSC-derived cardiomyocytes from patients with myotonic dystrophy type 1 have abnormal ion channel functions and slower conduction velocities.

Authors:  Hugo Poulin; Aurélie Mercier; Mohammed Djemai; Valérie Pouliot; Isabelle Deschenes; Mohamed Boutjdir; Jack Puymirat; Mohamed Chahine
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.379

4.  Case report: Novel SCN4A variant associated with a severe congenital myasthenic syndrome/myopathy phenotype.

Authors:  Veronika M Berghold; Mahmoud Koko; Riccardo Berutti; Barbara Plecko
Journal:  Front Pediatr       Date:  2022-08-26       Impact factor: 3.569

5.  Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy.

Authors:  Fernande Freyermuth; Frédérique Rau; Yosuke Kokunai; Thomas Linke; Chantal Sellier; Masayuki Nakamori; Yoshihiro Kino; Ludovic Arandel; Arnaud Jollet; Christelle Thibault; Muriel Philipps; Serge Vicaire; Bernard Jost; Bjarne Udd; John W Day; Denis Duboc; Karim Wahbi; Tsuyoshi Matsumura; Harutoshi Fujimura; Hideki Mochizuki; François Deryckere; Takashi Kimura; Nobuyuki Nukina; Shoichi Ishiura; Vincent Lacroix; Amandine Campan-Fournier; Vincent Navratil; Emilie Chautard; Didier Auboeuf; Minoru Horie; Keiji Imoto; Kuang-Yung Lee; Maurice S Swanson; Adolfo Lopez de Munain; Shin Inada; Hideki Itoh; Kazuo Nakazawa; Takashi Ashihara; Eric Wang; Thomas Zimmer; Denis Furling; Masanori P Takahashi; Nicolas Charlet-Berguerand
Journal:  Nat Commun       Date:  2016-04-11       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.